DOI QR코드

DOI QR Code

Magnetic Resonance Venography Findings of Obstructed Hepatic Veins and the Inferior Vena Cava in Patients with Budd-Chiari Syndrome

  • Song, Ru-Xin (Department of Ultrasound, Shandong Provincial Hospital Affiliated to Shandong University) ;
  • Cai, Shi-Feng (Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong University) ;
  • Ma, Shuang (Department of Ultrasound, Fifth Hospital of Jinan) ;
  • Liu, Zhi-Ling (Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong University) ;
  • Gai, Yong-Hao (Department of Ultrasound, Shandong Provincial Hospital Affiliated to Shandong University) ;
  • Zhang, Chun-Qing (Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University) ;
  • Wang, Guang-Chuan (Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University)
  • Received : 2017.06.05
  • Accepted : 2017.10.02
  • Published : 2018.06.01

Abstract

Objective: This study aimed to illustrate the magnetic resonance venography (MRV) manifestations of obstructed hepatic veins (HVs), the inferior vena cava (IVC), and accessory hepatic veins (AHVs) in patients with Budd-Chiari syndrome (BCS) and to evaluate the visualization capacity of MRV in the diagnosis of BCS. Materials and Methods: Fifty-two patients with chronic BCS were included in this study. All patients were examined via MRV performed with a 3T system following injections of gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA) or Gd-ethoxibenzyl-DTPA. HV and IVC lesions were classified, and their characteristics were described. HV cord-like occlusions detected via MRV were compared using ultrasonography (US). Digital subtraction angiography (DSA) was performed as a contrast in the MRV detection of IVC lesions. The HVs draining collaterals, mainly AHVs, were carefully observed. HV lesions were classified as segmental stenosis, segmental occlusion, membranous stenosis, membranous occlusion, cord-like occlusion, or non-visualized. Except for patent IVCs, IVC lesions were classified as segmental occlusion, segmental stenosis, membranous occlusion, membranous stenosis, and hepatomegaly-induced stenosis. Results: All patients (52/52, 100%) showed HV lesions of different degrees. MRV was inferior to US in detecting cord-like occlusions (6 vs. 19, ${\chi}^2=11.077$, p < 0.001). Dilated AHVs, including 50 (50/52, 96.2%) caudate lobe veins and 37 (37/52, 71.2%) inferior HV and AHV lesions, were well-detected. There were no significant differences in detecting segmental lesions and thrombosis between MRV and DSA (${\chi}^2=0.000$, p1 = 1.000, p2 = 1.000). The capacity of MRV to detect membranous lesions was inferior to that of DSA (7 vs. 15, ${\chi}^2=6.125$, p = 0.013). Conclusion: In patients with BCS, MRV can clearly display the lesions in HVs and the IVC, as well as in AHVs, and it has diagnostic and therapeutic value.

Keywords

References

  1. Hefaiedh R, Cheikh M, Marsaoui L, Ennaifer R, Romdhane H, Ben Nejma H, et al. The Budd-Chiari syndrome. Tunis Med 2013;91:376-381
  2. Hidaka M, Eguchi S. Budd-Chiari syndrome: focus on surgical treatment. Hepatol Res 2017;47:142-148 https://doi.org/10.1111/hepr.12752
  3. Klein AS. Management of Budd-Chiari syndrome. Liver Transpl 2006;12:S23-S28 https://doi.org/10.1002/lt.20941
  4. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009;50:195-203 https://doi.org/10.1016/j.jhep.2008.10.007
  5. Gai YH. [Sonographic classification of blood-drainage in Budd-Chiari syndrome with hepatic vein obstruction]. Chin J UItrasonogr 2008;6:517-520
  6. Gai YH, Ma S, Guo WB, Liang B, JIA T, Zhang SZ, et al. [Further study of sonographic examination skills and classifications of the inferior vena cava lesions in patients with Budd-Chiari syndrome]. Chin J UItrasonogr 2012;11:965-968
  7. Gai YH, Cai SF, Guo WB, Zhang CQ, Liang B, Jia T, et al. Sonographic classification of draining pathways of obstructed hepatic veins in Budd-Chiari syndrome. J Clin Ultrasound 2014;42:134-142 https://doi.org/10.1002/jcu.22107
  8. Bargallo X, Gilabert R, Nicolau C, Garcia-Pagan JC, Bosch J, Bru C. Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome. AJR Am J Roentgenol 2003;181:1641-1645 https://doi.org/10.2214/ajr.181.6.1811641
  9. Kanamura T, Murakami G, Hirai I, Hata F, Sato TJ, Kumon M, et al. High dorsal drainage routes of Spiegel's lobe. J Hepatobiliary Pancreat Surg 2001;8:549-556 https://doi.org/10.1007/s005340100024
  10. Xing X, Li H, Liu WG. Clinical studies on inferior right hepatic veins. Hepatobiliary Pancreat Dis Int 2007;6:579-584
  11. Lu X, Yang C, Xu K, Rong YT, Li SD, Li JS, et al. Magnetic resonance venography in the diagnosis of inferior vena cava obstruction in Budd-Chiari syndrome. Eur Rev Med Pharmacol Sci 2015;19:256-264
  12. Faraoun SA, Boudjella Mel A, Debzi N, Afredj N, Guerrache Y, Benidir N, et al. Budd-Chiari syndrome: a prospective analysis of hepatic vein obstruction on ultrasonography, multidetectorrow computed tomography and MR imaging. Abdom Imaging 2015;40:1500-1509 https://doi.org/10.1007/s00261-015-0380-5
  13. Standring S. Gray's anatomy, 40th ed. London: Churchill Livingstone, 2008:2108
  14. Ueda K, Matsui O, Kadoya M, Yoshikawa J, Gabata T, Kawamori Y, et al. CTAP in budd-chiari syndrome: evaluation of intrahepatic portal flow. Abdom Imaging 1998;23:304-308 https://doi.org/10.1007/s002619900346
  15. Cai SF, Gai YH, Ma S, Liang B, Wang GC, Liu QW. Ultrasonographic visualization of accessory hepatic veins and their lesions in Budd-Chiari syndrome. Ultrasound Med Biol 2015;41:2091-2098 https://doi.org/10.1016/j.ultrasmedbio.2015.03.023
  16. Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-S38
  17. Xue H, Li YC, Shakya P, Palikhe M, Jha RK. The role of intravascular intervention in the management of Budd-Chiari syndrome. Dig Dis Sci 2010;55:2659-2663 https://doi.org/10.1007/s10620-009-1087-7
  18. Cura M, Haskal Z, Lopera J. Diagnostic and interventional radiology for Budd-Chiari syndrome. Radiographics 2009;29:669-681 https://doi.org/10.1148/rg.293085056
  19. Xu PQ, Dang XW. Treatment of membranous Budd-Chiari syndrome: analysis of 480 cases. Hepatobiliary Pancreat Dis Int 2004;3:73-76
  20. Wang ZG. Experience on management of Budd-Chiari syndrome in 143 cases. Angio Arch 1989;17:147-152
  21. Yang C, Li C, Zeng M, Lu X, Li J, Wang J, et al. Non-contrastenhanced MR angiography in the diagnosis of Budd- Chiari syndrome (BCS) compared with digital subtraction angiography (DSA): preliminary results. Magn Reson Imaging 2017;36:7-11 https://doi.org/10.1016/j.mri.2016.10.006
  22. Shimada K, Isoda H, Okada T, Kamae T, Arizono S, Hirokawa Y, et al. Non-contrast-enhanced hepatic MR angiography: do two-dimensional parallel imaging and short tau inversion recovery methods shorten acquisition time without image quality deterioration? Eur J Radiol 2011;77:137-142 https://doi.org/10.1016/j.ejrad.2009.05.051

Cited by

  1. Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis vol.93, pp.1109, 2020, https://doi.org/10.1259/bjr.20190847
  2. Ultrasonic Evaluation of Spontaneous Portosystemic Shunts in Patients with Budd-Chiari Syndrome vol.17, pp.4, 2018, https://doi.org/10.5812/iranjradiol.103658